Search for Clinical Trial Results

Sponsored By

Paratuberculosis - 3 Studies Found

Status Study
Completed Study Name: Treatment of Crohn's Disease With an Antibiotic Regimen Directed Against Mycobacterium Avium Paratuberculosis
Condition: Crohn's Disease
Date: 2007-08-06
Interventions: Drug: Rifabutin, Clarithromycin, and Clofazimine Rifabutin 150 mg by mouth twice daily, Clarithromycin 2
Recruiting Study Name: Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's Disease
Condition: Crohn Disease
Date: 2016-12-26
Interventions: Drug: RHB-104 RHB-104; a fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clof
Recruiting Study Name: A Study to Determine the Safety and Immunogenicity of a Candidate MAP Vaccine ChAdOx2 HAV in Healthy Adult Volunteers
Condition: Crohn Disease
Date: 2017-01-19
Interventions: Biological: ChAdOx2 HAV The ChAdOx2 HAV vaccine consists of the replication-deficient simian adenovirus